Amitriptyline is sometimes used to treat arm pain related to repetitive use, but rigorous evidence of its benefit is lacking. This randomized controlled trial investigated whether amitriptyline provided greater pain relief or improved arm function than a placebo pill in adults with arm pain associated with repetitive use that had persisted for at least 3 months. Participants (N = 118) were randomly assigned to receive 25 mg of amitriptyline or a placebo pill for 6 weeks. The primary outcome was intensity of pain (10-point numerical rating scale) and secondary outcomes were arm symptoms, arm function, grip strength, mood, and sleep. Assessments were done at baseline, 3 and 6 weeks of treatment, and 1 month after treatment ended. Changes in arm pain were not statistically significant. However, the amitriptyline group improved more than the placebo group in arm function (p = 0.023) and sense of well being (p = 0.034). In a longitudinal analysis, the amitriptyline group's arm function score improved 0.45 points per week faster than placebo after adjusting for subject characteristics (p = 0.015). At the treatment's midpoint, the amitriptyline group reported more ''troublesome side-effects" than the placebo group (52.5% vs. 27.1%, p = 0.005), but this difference decreased by end of treatment (30.5% vs. 22.0%, p = 0.30). The most frequent side effect was drowsiness. In conclusion, this study found that low-dose amitriptyline did not significantly decrease arm pain among these participants but did significantly improve arm function and well being. Future research is needed to explore the effects of higher doses and longer duration of treatment.
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Introduction
Arm pain from repetitive use -termed repetitive motion disorders (RMDs) [23] , cumulative trauma disorders, work-related musculoskeletal disorders (WMSDs) [1,25], or repetitive strain injuries [34, 35] -is an important cause of workplace disability. According to the US Bureau of Labor Statistics, repetitive motion including grasping tools, scanning groceries, and typing has resulted in the longest absences from work among leading events and exposures [3] . Like low back pain, RMDs of the upper extremity can derive from tendons, nerves, or muscles and encompass a wide range of diagnoses, including lateral and medial epicondylitis, tendonitis, and carpal tunnel syndrome, as well as non-specific arm pain Tricyclic antidepressants have been shown to be effective in decreasing pain associated with diabetic neuropathy and postherpetic neuralgia [15, 17, 18, 21] . In addition to neuropathic conditions, tricyclics have been found to be useful in the treatment of fibromyalgia and headaches [2, 8, 10, 15] . Antidepressants also have been used to treat chronic low back pain and found to be effective in reducing pain severity, but with conflicting evidence about improvement in functional status [29, 31] . Despite similarities between chronic upper extremity syndromes and chronic low back pain, we could find no randomized controlled studies examining
